These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

827 related items for PubMed ID: 10684852

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Refining the rules of gliadin T cell epitope binding to the disease-associated DQ2 molecule in celiac disease: importance of proline spacing and glutamine deamidation.
    Qiao SW, Bergseng E, Molberg O, Jung G, Fleckenstein B, Sollid LM.
    J Immunol; 2005 Jul 01; 175(1):254-61. PubMed ID: 15972656
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Single-chain recombinant HLA-DQ2.5/peptide molecules block α2-gliadin-specific pathogenic CD4+ T-cell proliferation and attenuate production of inflammatory cytokines: a potential therapy for celiac disease.
    Huan J, Meza-Romero R, Mooney JL, Vandenbark AA, Offner H, Burrows GG.
    Mucosal Immunol; 2011 Jan 01; 4(1):112-20. PubMed ID: 20736999
    [Abstract] [Full Text] [Related]

  • 11. Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion.
    Qiao SW, Bergseng E, Molberg Ø, Xia J, Fleckenstein B, Khosla C, Sollid LM.
    J Immunol; 2004 Aug 01; 173(3):1757-62. PubMed ID: 15265905
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease.
    Molberg O, Mcadam SN, Körner R, Quarsten H, Kristiansen C, Madsen L, Fugger L, Scott H, Norén O, Roepstorff P, Lundin KE, Sjöström H, Sollid LM.
    Nat Med; 1998 Jun 01; 4(6):713-7. PubMed ID: 9623982
    [Abstract] [Full Text] [Related]

  • 18. Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides.
    Aleanzi M, Demonte AM, Esper C, Garcilazo S, Waggener M.
    Clin Chem; 2001 Nov 01; 47(11):2023-8. PubMed ID: 11673371
    [Abstract] [Full Text] [Related]

  • 19. Modelling of HLA-DQ2 and its interaction with gluten peptides to explain molecular recognition in celiac disease.
    Costantini S, Rossi M, Colonna G, Facchiano AM.
    J Mol Graph Model; 2005 Apr 01; 23(5):419-31. PubMed ID: 15781184
    [Abstract] [Full Text] [Related]

  • 20. Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues.
    Arentz-Hansen H, McAdam SN, Molberg Ø, Fleckenstein B, Lundin KE, Jørgensen TJ, Jung G, Roepstorff P, Sollid LM.
    Gastroenterology; 2002 Sep 01; 123(3):803-9. PubMed ID: 12198706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.